Anti-amyloid drugs likely provide no "clinically meaningful" effects for people with Alzheimer's, the authors concluded.

Alzheimer’s “wonder drugs” do not work, scientists have found in a study that overturns decades of research into the disease.

Critics say the meta-analysis provides an inaccurate picture of anti-amyloid medications. Two of them have FDA approval.

The Alzheimer's Association will host the 39th annual Rita Hayworth Gala on Saturday, May 9 at The Old Post Office (433 W Van Buren St), bringing together Chicago's civic, corporate and philanthropic ...

The review said a certain class of drugs had little clinical benefit, but many Alzheimer’s experts criticized the analysis, ...

A major review has provoked a backlash after concluding the medicines provide too little benefit to be noticed.

The secret might be hidden in our blood. Boston researchers in a new study have found that a blood test can predict Alzheimer’s disease progression years before symptoms or brain scan changes. The ...

Drugs once hailed as a breakthrough in the fight against Alzheimer's disease do not meaningfully help patients, a major ...

A new study from Mass General Brigham suggests a blood test may detect early biological signs of Alzheimer’s disease earlier ...

Alzheimer's Society responds to the claim that amyloid-targeting drugs show no clinically meaningful positive effects.

Janet Noon died of a pulmonary thromboembolism after paramedics and her doctor decided it was in her "best interest" not to ...

Drugs once hailed as a breakthrough in the fight against Alzheimer's disease do not meaningfully help patients, a major ...